404 related articles for article (PubMed ID: 10708438)
1. Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.
Sonoda K; Sakaguchi M; Okamura H; Yokogawa K; Tokunaga E; Tokiyoshi S; Kawaguchi Y; Hirai K
J Virol; 2000 Apr; 74(7):3217-26. PubMed ID: 10708438
[TBL] [Abstract][Full Text] [Related]
2. Protection of chickens with or without maternal antibodies against both Marek's and Newcastle diseases by one-time vaccination with recombinant vaccine of Marek's disease virus type 1.
Sakaguchi M; Nakamura H; Sonoda K; Okamura H; Yokogawa K; Matsuo K; Hira K
Vaccine; 1998 Mar; 16(5):472-9. PubMed ID: 9491501
[TBL] [Abstract][Full Text] [Related]
3. Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek's diseases in specific-pathogen-free chickens.
Reddy SK; Sharma JM; Ahmad J; Reddy DN; McMillen JK; Cook SM; Wild MA; Schwartz RD
Vaccine; 1996 Apr; 14(6):469-77. PubMed ID: 8782342
[TBL] [Abstract][Full Text] [Related]
4. Protection of chickens, with or without maternal antibodies, against IBDV infection by a recombinant IBDV-VP2 protein.
Zhou X; Wang D; Xiong J; Zhang P; Li Y; She R
Vaccine; 2010 May; 28(23):3990-6. PubMed ID: 20338216
[TBL] [Abstract][Full Text] [Related]
5. Lack of contact transmission of recombinant Marek's disease virus type 1 expressing the fusion protein of Newcastle disease virus.
Okamura H; Sakaguchi M; Yokogawa K; Tokunaga E; Abe S; Tokiyoshi S; Mizuno K
Vaccine; 2001 Nov; 20(3-4):483-9. PubMed ID: 11672913
[TBL] [Abstract][Full Text] [Related]
6. Efficacy in chickens of a herpesvirus of turkeys recombinant vaccine containing the fusion gene of Newcastle disease virus: onset of protection and effect of maternal antibodies.
Morgan RW; Gelb J; Pope CR; Sondermeijer PJ
Avian Dis; 1993; 37(4):1032-40. PubMed ID: 8141730
[TBL] [Abstract][Full Text] [Related]
7. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox.
Sharma JM; Zhang Y; Jensen D; Rautenschlein S; Yeh HY
Avian Dis; 2002; 46(3):613-22. PubMed ID: 12243525
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek's disease viruses.
van Hulten MCW; Cruz-Coy J; Gergen L; Pouwels H; Ten Dam GB; Verstegen I; de Groof A; Morsey M; Tarpey I
Avian Pathol; 2021 Feb; 50(1):18-30. PubMed ID: 33063529
[TBL] [Abstract][Full Text] [Related]
9. A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek's diseases.
Gergen L; Cook S; Ledesma B; Cress W; Higuchi D; Counts D; Cruz-Coy J; Crouch C; Davis P; Tarpey I; Morsey M
Avian Pathol; 2019 Feb; 48(1):45-56. PubMed ID: 30404540
[TBL] [Abstract][Full Text] [Related]
10. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
[TBL] [Abstract][Full Text] [Related]
12. Newcastle disease virus (NDV) recombinant expressing Marek's disease virus (MDV) glycoprotein B significantly protects chickens against MDV and NDV challenges.
He L; Spatz S; Dunn JR; Yu Q
Vaccine; 2023 Sep; 41(40):5884-5891. PubMed ID: 37598026
[TBL] [Abstract][Full Text] [Related]
13. Recombinant fowlpox virus vaccines against Australian virulent Marek's disease virus: gene sequence analysis and comparison of vaccine efficacy in specific pathogen free and production chickens.
Heine HG; Foord AJ; Young PL; Hooper PT; Lehrbach PR; Boyle DB
Virus Res; 1997 Jul; 50(1):23-33. PubMed ID: 9255932
[TBL] [Abstract][Full Text] [Related]
14. Effects of different promoters on the protective efficacy of recombinant Marek's disease virus type 1 expressing the VP2 gene of infectious bursal disease virus.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Gao Y; Cui H; Qi X; Zhong L; Wang X
Vaccine; 2016 Nov; 34(47):5744-5750. PubMed ID: 27742216
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
[TBL] [Abstract][Full Text] [Related]
16. Application of a new bivalent Marek's disease vaccine does not interfere with infectious bronchitis or Newcastle disease vaccinations and proves efficacious.
Rahaus M; Augustinski K; Castells M; Desloges N
Avian Dis; 2013 Jun; 57(2 Suppl):498-502. PubMed ID: 23901767
[TBL] [Abstract][Full Text] [Related]
17. Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine.
Esaki M; Godoy A; Rosenberger JK; Rosenberger SC; Gardin Y; Yasuda A; Dorsey KM
Avian Dis; 2013 Dec; 57(4):750-5. PubMed ID: 24597117
[TBL] [Abstract][Full Text] [Related]
18. Construction of recombinant Marek's disease virus type 1 (MDV1) expressing the Escherichia coli lacZ gene as a possible live vaccine vector: the US10 gene of MDV1 as a stable insertion site.
Sakaguchi M; Hirayama Y; Maeda H; Matsuo K; Yamamoto M; Hirai K
Vaccine; 1994 Aug; 12(10):953-7. PubMed ID: 7975837
[TBL] [Abstract][Full Text] [Related]
19. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric deletion of the junction between the short unique region and the inverted repeat does not affect viral growth in culture and vaccine-induced immunity against Marek's disease.
Sonoda K; Sakaguchi M; Matsuo K; Zhu GS; Hirai K
Vaccine; 1996 Mar; 14(4):277-84. PubMed ID: 8744553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
